Financials Voronoi, Inc.

Equities

A310210

KR7310210000

Biotechnology & Medical Research

End-of-day quote Korea S.E. 18:00:00 2024-05-30 EDT 5-day change 1st Jan Change
41,500 KRW -0.36% Intraday chart for Voronoi, Inc. +13.39% -23.15%

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 418,266 913,616 717,959 -
Enterprise Value (EV) 2 418.3 913.1 764 799
P/E ratio -20 x -22.5 x -24.1 x -21.9 x
Yield - - - -
Capitalization / Revenue - - 55.2 x 39.9 x
EV / Revenue - - 58.8 x 44.4 x
EV / EBITDA - -31.9 x -34.7 x -34.7 x
EV / FCF - -29.7 x -25.5 x -23.5 x
FCF Yield - -3.36% -3.93% -4.26%
Price to Book - 10.2 x -20 x -9.83 x
Nbr of stocks (in thousands) 14,698 16,919 17,300 -
Reference price 3 28,458 54,000 41,500 41,500
Announcement Date 3/23/23 2/15/24 - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales 1 - - 13 18
EBITDA 1 - -28.64 -22 -23
EBIT 1 - -31.34 -23 -24
Operating Margin - - -176.92% -133.33%
Earnings before Tax (EBT) - - - -
Net income 1 -19.9 -36.85 -30 -32
Net margin - - -230.77% -177.78%
EPS 2 -1,426 -2,401 -1,724 -1,891
Free Cash Flow 3 - -30,700 -30,000 -34,000
FCF margin - - -230,769.23% -188,888.89%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 3/23/23 2/15/24 - -
1KRW in Billions2KRW3KRW in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt 1 - - 46 81
Net Cash position 1 - 0.56 - -
Leverage (Debt/EBITDA) - - -2.091 x -3.522 x
Free Cash Flow 2 - -30,700 -30,000 -34,000
ROE (net income / shareholders' equity) - -63.9% - -
ROA (Net income/ Total Assets) - -46.5% -41.1% -56.4%
Assets 1 - 79.3 72.99 56.74
Book Value Per Share 3 - 5,301 -2,078 -4,222
Cash Flow per Share - - - -
Capex - - - -
Capex / Sales - - - -
Announcement Date 3/23/23 2/15/24 - -
1KRW in Billions2KRW in Million3KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
41,500 KRW
Average target price
85,000 KRW
Spread / Average Target
+104.82%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A310210 Stock
  4. Financials Voronoi, Inc.